腹腔镜与开腹中段胰腺切除伴胰空肠吻合的临床结局与生活质量比较
本研究回顾1997至2015年间36例中段胰腺切除伴胰空肠吻合患者(腹腔镜17例,开腹19例),比较两组临床结局与SF-36生活质量。腹腔镜组估计失血量更少、排气和进食更早,但术后住院时间和并发症无显著差异;生活质量总分及躯体、心理健康评分无显著差异,仅角色躯体维度腹腔镜组显著更高。
要点
- 腹腔镜中段胰腺切除伴胰空肠吻合安全可行,适用于胰颈及近端胰体良性或交界性病变。
- 腹腔镜组估计失血量显著少于开腹组,术后排气和进食时间更早。
- 两组术后住院时间、并发症、胰瘘率和死亡率无显著差异。
核心结论
- 腹腔镜中段胰腺切除伴胰空肠吻合治疗胰颈及近端胰体良性或交界性病变安全可行。
- 与开腹相比,腹腔镜组估计失血量更少、恢复更快、生活质量更好。
研究设计与样本
- 回顾性队列研究,纳入1997年12月至2015年12月行中段胰腺切除伴胰空肠吻合的患者36例。
- 患者分为腹腔镜中段胰腺切除组(LCP,17例)和开腹中段胰腺切除组(OCP,19例)。
- 比较指标包括人口学资料、术中变量、并发症、术后住院时间、死亡率、病理结果及SF-36生活质量问卷。
主要发现
- 手术时间两组相似(280.4 ± 33.6 vs. 290.5 ± 62.5 min,p = 0.455)。
- LCP组估计失血量显著低于OCP组(76.4 ± 70.3 vs. 390.3 ± 279.0 ml,p = 0.001)。
- LCP组首次排气时间(2.4 ± 0.9 vs. 3.9 ± 1.3天,p = 0.001)和开始进食时间(4.1 ± 2.2 vs. 6.1 ± 2.4天,p = 0.030)显著更短。
- 术后住院时间两组无显著差异(15.6 ± 12.1 vs. 24.0 ± 27.5天,p = 0.347)。
- 并发症发生率(58.8 vs. 52.6%,p = 0.749)和≥B级胰瘘率(17.6 vs. 36.8%,p = 0.106)两组无显著差异。
关键数值与推荐
- 中位随访45个月(范围4-216个月),两组均未检出局部复发或远处转移。
- SF-36总分(702.9 ± 47.9 vs. 671.8 ± 94.1)、躯体健康评分(353.9 ± 24.8 vs. 326.6 ± 67.6)和心理 health评分(349.0 ± 26.5 vs. 345.2 ± 34.6)在LCP组更高,但差异无统计学意义(p > 0.05)。
- 角色躯体维度评分LCP组显著更高(100 vs. 73.1 ± 4.8,p = 0.042),其他领域无显著差异(p > 0.05)。
临床怎么用
- 对于胰颈及近端胰体良性或交界性病变,腹腔镜中段胰腺切除伴胰空肠吻合可作为开腹手术的可行替代。
- 腹腔镜入路可能减少术中失血并加速术后胃肠功能恢复。
- 术后并发症和胰瘘风险与开腹手术相当,需常规关注。
局限性
- 样本量小(共36例),可能影响统计效能。
- 回顾性研究设计,存在选择偏倚可能。
- 生活质量随访数据非同期对照,且部分维度差异未达统计学显著。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The studies comparing laparoscopic and open central pancreatectomy with pancreaticojejunostomy are limited. This study aimed to compare clinical outcomes and quality of life of patients undergoing laparoscopic and open central pancreatectomy with pancreaticojejunostomy. METHODS: Between December 1997 and December 2015, patients who underwent central pancreatectomy with pancreaticojejunostomy were reviewed. Patients were divided into 2 groups as laparoscopic central pancreatectomy (LCP) and open central pancreatectomy (OCP). Data considered for comparison analysis were patient demographics, intraoperative variables, morbidity, postoperative hospital stay, mortality, pathologic findings, and quality of life (SF-36 questionnaire). RESULTS: Thirty-six patients (17 LCP and 19 OCP) were included in the final analysis. Baseline characteristics were similar in the 2 groups. The operating time (280.4 ± 33.6 vs. 290.5 ± 62.5 min, p = 0.455) were similar between two groups. LCP group showed significantly lower estimated blood loss (76.4 ± 70.3 vs. 390.3 ± 279.0 ml, p = 0.001), shorter first flatus time (2.4 ± 0.9 vs. 3.9 ± 1.3 days, p = 0.001), and shorter diet start time (4.1 ± 2.2 vs. 6.1 ± 2.4 days, p = 0.030). However, the postoperative hospital stay was not significantly different between two groups (15.6 ± 12.1 vs. 24.0 ± 27.5 days, p = 0.347). Postoperative outcomes, including morbidity (58.8 vs. 52.6%, p = 0.749), pancreatic fistula rates (≥grade B: 17.6 vs. 36.8%, p = 0.106), and mortality, were similar in the 2 groups. The median follow-up period was 45 months (range 4-216 months). No local recurrence or distant metastasis was detected in either group. On the follow-up survey, the total quality of life score (702.9 ± 47.9 vs. 671.8 ± 94.1), physical health score (353.9 ± 24.8 vs. 326.6 ± 67.6) and mental health score (349.0 ± 26.5 vs. 345.2 ± 34.6) were higher in the LCP group compared with the OCP group. However, these differences were not statistically significant (p > 0.05). The score in role physical (100 vs. 73.1 ± 4.8, p = 0.042) was significantly higher in LCP group, and not statistically significant in other areas (p > 0.05). CONCLUSIONS: LCP with pancreaticojejunostomy is safe and feasible for benign or borderline malignant lesions in the pancreatic neck and proximal body. Compared to OCP, LCP is associated with lower estimated blood loss, faster recovery, and better quality of life.
引用
- Zhang RC, Zhang B, Mou YP, et al. Comparison of clinical outcomes and quality of life between laparoscopic and open central pancreatectomy with pancreaticojejunostomy. Surg Endosc. 2017. PMID: 28424909. doi:10.1007/s00464-017-5552-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。